A. Khani-hanjani et al., Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis, LANCET, 356(9232), 2000, pp. 820-825
Citations number
35
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Background Rheumatoid arthritis ranges from a mild, non-deforming arthropat
hy with little long-term disability to severe, incapacitating, deforming ar
thritis which may be refractory to conventional disease-modifying agents. E
pidemiological studies show an important genetic influence in rheumatoid ar
thritis, and MHC region genes and cytokine genes within and outside this re
gion have been considered as candidates. We did a case-control study to tes
t whether polymorphisms in the interferon-gamma gene are associated with se
verity of rheumatoid arthritis.
Methods Interferon gamma dinucleotide repeat polymorphisms were examined wi
th quantitative genescan technology, and HLA-DR alleles were identified by
PCR and restriction-fragment-length polymorphism analysis. We studied 60 pa
tients with severe rheumatoid arthritis, 39 with mild disease, and 65 norma
l controls.
Findings Susceptibility to, and severity of, rheumatoid arthritis were rela
ted to a microsatellite polymorphism within the first intron of the interfe
ron-gamma gene. A 126 bp allele was seen in 44 (73%) of 60 patients with se
vere rheumatoid arthritis, compared with eight (21%) of 39 with mild diseas
e (odds ratio 10.66 [95% CI 4.1-24.9]), and with eight (12%) of 65 normal c
ontrols (19.59 [7.7-49.9]). Conversely, a 122 bp allele at the same locus w
as found in four (7%) patients with severe disease compared with 25 (64%) o
f those with mild disease (0.04 [0.01-0.1]) and with 52 (80%) of controls (
0.018 [0.005-0.06]).
Interpretation This association may be valuable for understanding the mecha
nism of disease progression, for predicting the course of the disease, and
for guiding therapy.